Market Closed -
Other stock markets
|
After market 06:01:22 pm | |||
311.4 USD | -1.45% | 310.8 | -0.20% |
Apr. 25 | UBS Cuts Humana's Price Target to $326 From $334, Maintains Neutral Rating | MT |
Apr. 25 | Jefferies Adjusts Price Target on Humana to $365 From $381 | MT |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The stock, which is currently worth 2024 to 0.37 times its sales, is clearly overvalued in comparison with peers.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company sustains low margins.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Managed Healthcare
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-31.98% | 38.08B | A- | ||
-6.19% | 448B | B- | ||
+14.45% | 124B | A- | ||
+18.39% | 99.92B | B- | ||
+1.98% | 40.75B | B- | ||
-2.49% | 21.52B | B- | ||
-40.07% | 979M | B- | ||
-29.63% | 322M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- HUM Stock
- Ratings Humana Inc.